BMSCs were treated with OI at different time points and showed increases in ALP activity, degree of mineralization (P < 0.05, Figures 2(a) and 2(b)), and expression levels of OPN and OCN (P < 0.05, Figure 2(c)). This evidence concerns the gene BGLAP and osteogenesis imperfecta.